Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbial metalloenzymes involved in DNA replication and related processes constitute a broad functional class of proteins that require metal ions—such as magnesium, zinc, iron, or manganese—as essential cofactors for their catalytic activity or structural stability (Source: UniProt; Nature Reviews Microbiology). This group includes critical enzymes such as ribonucleotide reductases (RNR), which catalyze the rate-limiting step in deoxyribonucleotide synthesis, as well as DNA polymerases, primases, and topoisomerases responsible for genome duplication and maintenance (Source: Journal of Biological Chemistry). These enzymes are fundamental to the survival and proliferation of bacterial, viral, and fungal pathogens, making them significant targets for anti-infective drug development (Source: PubMed, PMID: 25658227). For example, the drug hydroxyurea inhibits RNR by disrupting its metal-dependent tyrosyl radical, while foscarnet targets the metal-binding site of viral DNA polymerases to halt replication (Source: StatPearls). A major challenge in targeting these enzymes is the structural similarity between microbial and human metalloenzymes, which can lead to off-target effects and host toxicity (Source: NIH, National Institute of Allergy and Infectious Diseases).
These enzymes utilize metal ion cofactors (e.g., Mg2+, Zn2+, Fe, Mn) to facilitate phosphoryl transfer, stabilize transition states, or generate catalytic radicals; drugs inhibit them by chelating these metal centers, mimicking pyrophosphate, or blocking the active site (Source: Nature Reviews Microbiology; Annual Review of Biochemistry).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial metalloenzymes involved in DNA replication and related processes.